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Abstract
Background: Accurate data on adherence and sexual behaviour are crucial in microbicide (and other HIV-related) research.
In the absence of a ‘‘gold standard’’ the collection of such data relies largely on participant self-reporting. The Microbicides
Development Programme has developed a mixed method/triangulation model for generating more accurate data on
adherence and sexual behaviour.
Methodology/Principal Findings: Data were collected from a random subsample of 725 women using structured case
record form (CRF) interviews, coital diaries (CD) and in-depth interviews (IDI). Returned used and unused gel applicators
were counted and additional data collected through focus group discussions and ethnography. The model is described in
detail in a companion paper [1]. When CRF, CD and IDI are compared there is some inconsistency with regard to reporting
of sexual behaviour, gel or condom use in more than half. Inaccuracies are least prevalent in the IDI and most prevalent in
the CRF, where participants tend to under-report frequency of sex and gel and condom use. Women reported more sex, gel
and condom use than their partners. IDI data on adherence match the applicator-return data more closely than the CRF. The
main reasons for inaccuracies are participants forgetting, interviewer error, desirability bias, problems with the definition
and delineation of key concepts (e.g. ‘‘sex act’’). Most inaccuracies were unintentional and could be rectified during data
collection.
Conclusions/Significance: The CRF – the main source of self-report data on behaviour and adherence in many studies – was
the least accurate with regard to measuring sexual behaviour, gel and condom use. This has important implications for the
use of structured questionnaires for the collection of data on sexual behaviour and adherence. Integrating in-depth
interviews and triangulation into clinical trials could increase the richness and accuracy of behavioural and adherence data.
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Introduction
The accurate measurement of product use and sexual behaviour
is extremely important in microbicide and other related clinical
trials. First, poor adherence reduces the chance of demonstrating
effectiveness. If a trial shows overall benefit then relating the level
of protection to adherence is valuable in interpreting the results,
and has important implications for predicting effectiveness in real-
life settings. Also, in order to properly interpret the results of trials
that do not show a protective effect, it is necessary to be able to
identify to what extent this may be due to the product not being
efficacious, participants not using it or not using it correctly,
participants increasing protective behaviours such as condom use,
increased risky behaviour related to perceived protection of the
product, or other high-risk behaviours [2,3]. Second, the use of
investigational microbicides may negatively affect participants,
either directly as a result of harmful side effects or indirectly as a
result of changes in behaviour. Having accurate data on product
use and related behaviour is important for assessing safety [2,3].
Third, understanding the reasons for different levels of adherence
provides insights that are useful for the design of future clinical
trials and for facilitating rollout and access if the product proves
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effective. Finally, understanding the reasons for non-adherence
and for not reporting or inaccurately reporting non-adherence and
other relevant behaviours is also important because it can be fed
back into the trial and used to improve adherence and the
accuracy of adherence data. Similarly, understanding the issues
involved in the inaccurate reporting of sexual behaviour and other
relevant practices during the trial makes it possible to adjust data
collection techniques and improve accuracy.
In the absence of a ‘‘gold standard’’ the collection of data on
adherence, and sexual and other sensitive behaviour relies largely
on participant self-reporting, the limitations of which are well
recognised. In order to overcome these limitations in the
Microbicides Development Programme (MDP) – an international
partnership set up to evaluate vaginal microbicides to prevent HIV
transmission (www.mdp.mrc.ac.uk) – developed a mixed method
and triangulation model to collect data on sexual behaviour and
adherence in the MDP301 trial. This was a multi-centre,
randomised, double-blind, placebo controlled trial that aimed to
determine the efficacy and safety of PRO-2000 gel in preventing
vaginally acquired HIV infection. It was carried out at six research
centres: three in South Africa, and one each in Zambia, Uganda
and Tanzania and enrolled 9,385 women who were followed up
for 12 months post-randomisation (24 months in Uganda) [4]. The
results of the MDP301 trial were announced in late 2009, showing
no evidence that PRO-2000 provided protection against HIV
infection.
This paper presents some of the data on sexual behaviour and
gel use collected using this model, revealing inconsistencies
between different methods and inaccuracies located mainly in
the structured case record form (CRF) interviews carried out in a
clinic setting – the main source of behavioural and adherence data
in many clinical trials. In addition, it reveals the nature and
location of inaccuracies and some of the misunderstandings arising
in the data collection process. It also shows that these inaccuracies
are largely unintentional, and that it is possible to identify and
correct most of them relatively easily through the use of mixed
methods and triangulation during the trial.
Methods
All trial participants had four-weekly clinic visits during which
they received gel supplies and condoms, returned used and
remaining unused gel applicators, and were interviewed in the
clinic using a case record form (CRF). The visits at weeks 4, 24, 40
and 52 were longer, including clinical examinations and a more
detailed CRF interview, containing questions about gel use,
vaginal washing and other practices, and detailed questions on
each sex act during the last week (or four weeks if the participant
did not have sex in the last week). A subsample of 725 women
(7.7% of the trial population) was randomly assigned to the social
science component of the trial, which was responsible for the
triangulation process. The triangulation procedures were linked to
three of these long clinic visits, at weeks 4, 24 and 52.
Four weeks prior to these visits the women in the subsample
received a coital diary (CD) in which they recorded howmany times
they had had sex and what kind of sex, whether or not they had used
the gel or a condom, vaginal hygiene practices, and various other
things. During the clinic visit they handed in their CD and all used
and unused gel applicators, which were counted. A member of the
clinic staff then interviewed them about the same topics as those in
the CD using a structured case record form (CRF).
Shortly after the clinic interview a member of the social science
team copied the key information on sexual behaviour, gel and
condom use from the CRF and the CD, as well as applicator
return data, onto a comparison form, which was integrated into
the in-depth interview guide. This enabled the interviewers to see
any inconsistencies at a glance. A few days later a social scientist
carried out an in-depth interview (IDI), focusing on the same
period as the CD and the CRF and on the same behavioural and
product-related topics, but in a more open and informal manner.
Answers to the questions on sexual behaviour and gel and condom
use were also noted on the comparison form. The interviewer also
probed to find out the reasons for any discrepancies between the
data from different methods, and attempted to establish the most
accurate answer in discussion with the participant. The final
corrected result was recorded on the comparison form. These
interviews were recorded digitally. Consenting male partners of
participants who agreed were also interviewed about sexual
behaviour during the same period.
The in-depth interview guide also contained a summary section
with pre-coded answers and summary fields so that the interviewer
could fill in the major findings during or immediately after the
interview. These data, together with key data from the CD and the
comparison form, were entered into a summary database that
provided quick access to the results in a quantitative format.
Where relevant, the information from the above process was fed
back to the local clinic teams and to the central Trial Management
Group during monthly calls to review progress.
Focus group discussions with trial participants and community
members about the gel, the trial, sexual behaviour and related
issues were carried out to collect more general information on
community attitudes. Ethnography was carried out in the research
communities and clinics. Sometimes these activities were aimed at
specific problems that arose during the trial.
Transcriptions from the recorded in-depth interviews, FGDs
and notes from the ethnography were entered and coded in Nvivo
(a software programme for the management and analysis of
qualitative data). Continuous analysis of the data was carried out
on a site level at the different research centres as well as centrally
across all sites.
The mixed method model is described in more detail in a
companion paper [1].
Altogether there are 1866 in-depth interviews, most with
matching CD, CRF and applicator count data, from the 725
women in the sub-sample. In addition there are 462 interviews
with 244 male partners, 100 FGDs with trial participants who
were not randomised to this sub sample, 119 FGDs with
community members, and extensive ethnographic notes. All the
qualitative data have been transcribed and coded in Nvivo (a
software package for managing and coding qualitative data).
The discussion in this paper is based on an analysis of in-depth
interview, coital diary and CRF data from 1636 clinic visits by 704
women: it only includes visits for which we have complete data on
reporting of sex, gel use and condom use from case record forms,
coital diaries and in-depth interviews. The focus then narrows to a
smaller sample of 1443 visits for which we also have matching
applicator return data. The women in these two smaller sub-
samples do not appear to be different in any way to those for
whom we do not have the full data from all clinic visits. In what
follows we shall refer to these collections of data derived from
different instruments but collected in relation to the week
preceding particular clinic visits as ‘‘datasets’’.
Results
Inconsistency and inaccuracy
Before proceeding we need to define what we mean by
consistent and inconsistent, and to clarify the relationship between
Assessing Adherence Data
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consistency and accuracy. If a participant gives the same answer to
the same question across the three different methods, then we call
this consistent (leaving aside the not unimportant philosophical
question of the extent to which a question can be considered ‘‘the
same’’ in the context of a structured CRF questionnaire, a coital
diary and an in-depth interview [1]. If the participant gives
different answers, then there is inconsistency. So for example, if a
woman reports three sex acts in the CRF interview but reports five
sex acts in the in-depth interview and records five in her coital
diary, then we consider her reporting of sex to be inconsistent.
This is made easier by the numerical nature of the answers, but
complicated by the fact that the behaviours being quantified are not
easy to delineate. For example, even though the trial defined ‘‘sex
act’’ as ‘‘a single act of vaginal penetration, with or without
ejaculation,’’ there is still much ambiguity regarding what counts as
a sex act, and the overlap in meaning with local concepts of ‘‘sex,’’
‘‘days’’ (on which people have sex), and ‘‘rounds’’ (there may be
numerous ‘‘rounds’’ of sex in a ‘‘day’’) is only partial. As a result, the
ostensibly unambiguous numbers hide a more ambiguous reality.
If a woman reports the frequency of a particular behaviour
consistently across all methods and there is nothing to suggest
otherwise, then we take this as the final, triangulated result. If there
are inconsistencies in reporting between the methods but these
inconsistencies are clarified in a plausible manner during the
discussion of inaccuracies in the in-depth interview, then the figure
agreed on in that discussion is taken as the final triangulated figure
(Figure 1).
We assume that the triangulated figure is the most accurate one
on pragmatic grounds, because it is plausible and there is no
evidence to the contrary, though of course there is no absolute way
of knowing this (here again we are avoiding philosophical
discussion). In most of the datasets with some inconsistency it is
Figure 1. Resolving inconsistency.
doi:10.1371/journal.pone.0011632.g001
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relatively straightforward to resolve this through probing and
discussion with the participant (Figure 1).
Extent of inconsistencies
The triangulation process revealed inconsistencies between the
data collected using CRF questionnaires, coital diaries and in-
depth interviews. Looking at the reporting of numbers of sex acts
in the last week/4 weeks, for example, there were inconsistencies
in 54% (876/1636) of the datasets. For the reporting of gel and
condom use this was 52% (850/1636) and 43% (705/1636)
respectively. Looking at all behaviours together, there was some
inconsistency in 60% (983/1636) of the datasets (Figure 2).
Of the 983 datasets with some inconsistency in the reporting of
any behaviour (i.e. the 60% in the right-hand column in Figure 2),
most involved inaccuracy in the reporting of all behaviours (59%)
or the reporting of both numbers of sex acts and gel use (20%).
Only 12% of the datasets contained inaccuracies relating to a
single behaviour.
Of course, the extent of inconsistency depends on how it is
defined. In Figure 2 ‘‘some inconsistency’’ refers to any inconsisten-
cy, ranging from very large discrepancies in different behaviours
and across different methods to small discrepancies in a single
method and relating to a single behaviour. In this ‘‘pessimistic’’
scenario, a woman who forgot to report a single sex act in her coital
diary would fall into the ‘‘inconsistent’’ category, together with a
woman who grossly misreported the number of sex acts, gel use and
condom use across different methods. A looser definition or
different criteria would result in less inconsistency. For example, if
we only compare the reported number of sex acts in the CRF with
the triangulated data 6 one sex act, then there is a 75% match (i.e.
higher than the 63% using perfect agreement), which increases to
82%6 two sex acts.
Differences in accuracy between the methods
Inaccuracies are not evenly distributed between the different
methods: if we assume that the triangulated data are most accurate
then the inaccuracies in the reporting of numbers of sex acts, gel
use and condom use are most prevalent in the CRF and least
prevalent in the in-depth interviews. For example, in 63% of the
CRF interviews the number of sex acts matches the triangulated
figure; for the CD this is 72% and for the IDI 84%. The figures are
very similar for condom and gel use (Table 1). Of course, it is more
likely that the IDI result will be closer to the triangulated result
because the IDI is central in establishing the triangulated result,
but there are reasons for arguing that this is more accurate. For
example the close match between IDI and CD data, the possibility
of probing answers, and the plausibility of answers given in the
IDI, and the fact that the probing in the IDI also reveals
inaccuracies in the IDI itself.
If we assume that the triangulated figure is the most accurate,
then most of the inaccuracy is in the CRF. However, this does not
mean that the triangulated result always agrees with the IDI. If, for
example, we look only at the 876 datasets that contain some
inconsistency in the reporting of number of sex acts, then it is clear
that there is substantial inaccuracy in the other methods as well:
68% of the CRFs, 53% of the coital diaries and 30% of the in-depth
interviews were inaccurate when compared to the triangulated data.
Differences in the reporting of the frequency of sex,
condom use and gel use between methods
If we compare individual methods, there was more reporting of all
behaviours (sex acts, gel use, and condom use) in the coital diary
compared to the CRF, and more in the in-depth interview compared
to the coital diary. The triangulated numbers are only marginally
higher than those from the IDIs. The differences between the coital
diaries, the in-depth interviews and the triangulated data are
relatively small compared to the difference between these and the
clinic CRF: participants reported 21% fewer sex acts, 16% fewer
condoms and 17% less gel use in the CRF compared to the
triangulated data; this is 6%, 4% and 5% respectively for the CD
when compared to the triangulated data (Table 1).
Figure 2. Proportion of datasets in which reporting of number of sex acts, gel use and condom in the last week/4 weeks are
consistent/inconsistent.
doi:10.1371/journal.pone.0011632.g002
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For the last week/4 weeks participants reported a mean number
of 4.5 sex acts in the CRF, 5.3 in the CD, 5.5 in the IDI and 5.7 in
the triangulated data. The mean number of gels they reported
using increases similarly from 4.0 in the CRF to 4.9 in the
triangulated data. Reported condom use increases from 3.1 in the
CRF to 3.7 in the triangulated data (Table 1).
On an individual level there was both over- and underreporting
of behaviours across all the methods. For example, in 30% of the
CRF interviews participants under-reported the number of sex
acts by 2205 compared to the triangulated data, and in 7% of the
CRF interviews they over-reported the number of sex acts by 298
compared to the triangulated data (Table 1).
Differences between partners
There were also inconsistencies between the participants’
reporting and that of their male partners. Altogether there were
462 interviews with 244 male partners of participant women.
These interviews covered the same one week/4 week period
covered by the women’s interviews. However, because of the
difficulty accessing the men (due to their work, mobility or
reluctance) these interviews were often too long after the women’s
interview to make them a reliable source of comparison, as the
men would be likely to have forgotten the details of their
behaviour and the exact days referred to in their partner’s
interview. As a result, what we present below is based only on the
372 interviews with 195 men that were conducted within one week
of their female partner’s interview.
On average women reported 10% more sex than their male
partners. They also reported 8% more gel use and 16% more
condom use. When individual couples are compared, men
reported differently to their partner’s triangulated number of sex
acts in 64% (238/372) of the interviews. In 109 cases the men
reported more sex than the triangulated figure for their partners,
and in 129 cases they report less (in eight cases she is talking
about the last 4 weeks while he means the last week). When
questioned about the discrepancy, men tended to say that they
thought that their partners’ answers were probably more
accurate because they were the ones keeping track due to the
trial, and because counting how often you had sex was a
‘‘woman thing’’.
Comparing self-reported gel use to returned used
applicators
The triangulation process based on discussion of inconsistencies
with participants and the degree of agreement between the IDI
and the CD strongly suggest that the CRF is the least accurate and
the IDI the most accurate of the three methods. But we do not
know for certain that this is the case, because we do not have any
independent, objective source of information on the behaviours in
question: we have only compared and triangulated different sets of
self-reported data and assessed participants’ explanations of the
discrepancies. However, we do have one additional source of data
on gel use: the gel applicator returns.
During their monthly clinic visits women were required to
return all used and unused applicators that they had received at
their previous visit. These were counted and recorded on a gel
accountability CRF, and women were asked to explain any
missing applicators. They then received a new supply of gel, the
number of applicators being based on their estimated need for the
coming month. For 1443 of the 1636 datasets used for this paper,
we also have matching data on returned applicators.
However, triangulating the self-report data on gel use with the
gel accountability data is not straightforward. Applicators were
collected monthly whereas the behavioural CRF and in-depth
interviews focused on the last week, except when women had not
had sex in that week, in which case the interviews focused on the
last four weeks. As a result, it is only possible to match reported gel
use and numbers of used applicators for the same time period for
this latter group of women (195/1443 datasets). For the majority of
women for whom we have applicator-return data (1248 datasets) it
is only possible to estimate average weekly gel use by dividing the
number of returned applicators by the number of weeks since the
last clinic visit. This makes anything more than an approximate
match for these women unreliable.
Bearing these limitations in mind, a comparison of self-reported
gel use from the different methods reveals that the total number of
returned used applicators matches the CD, IDI and triangulated
data more closely than the CRF. If we assume for the moment that
the number of used applicators represents the number of gels
actually used as intended, then overall there is some over-reporting
of gel use in the IDIs and triangulated data and under-reporting in
Table 1. Reporting of sex, gel use and condom use across the different methods.
METHOD CLINIC VISITS/DATASETS [behaviours] NO. OF BEHAVIOURS
Total Under-report Exact match Over-report Total (mean)
Diff. with
Triangulated
Sex CRF 1636 496 (30%) [2205] 1025 (63%) 115 (7%) [298] 7362 (4.5) 21907 (21%)
CD 317 (19%) [1202] 1183 (72%) 136 (8%) [629] 8696 (5.3) 2593 (6%)
IDI 147 (9%) [448] 1376 (84%) 113 (7%) [240] 9061 (5.5) 2208 (2%)
Triangulated 9269 (5.7)
Condom CRF 1636 335 (20%) [1403] 1150 (70%) 151 (9%) [408] 5109 (3.1) 2995 (16%)
CD 239 (15%) [832] 1258 (77%) 139 (8%) [564] 5838 (3.7) 2266 (4%)
IDI 97 (6%) [312] 1444 (88%) 95 (6%) [189] 5981 (3.7) 2123 (2%)
Triangulated 6104 (3.7)
Gel CRF 1636 425 (26%) [1843] 1033 (63%) 178 (11%) [459] 6556 (4.0) 21389 (17%)
CD 283 (17%) [1024] 1205 (74%) 148 (9%) [599] 7521 (4.6) 2424 (5%)
IDI 125 (8%) [385] 1394 (85%) 117 (7%) [260] 7820 (4.8) 2125 (2%)
Triangulated 7945 (4.9)
doi:10.1371/journal.pone.0011632.t001
Assessing Adherence Data
PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11632
the CD and CRF, with the IDI figures before triangulation being
closest to the applicator returns (Table 2).
As with the figures for numbers of sex acts, the cumulative
figures for reported gel use conceal individual variations in
reporting.
Reasons for discrepancy between data from different
sources
From the discussion in the IDIs, many reasons for the
differences in reporting of sexual behaviour and gel use between
the different methods became clear. They tend to fall into four
main categories. These categories are not exclusive, however, and
some of the issues discussed below fit under more than one
heading.
Practical.
1. Participants forgetting (particularly during the CRF interview)
how often they had had sex and how many gels and condoms
they had used.
2. CRF interviewers not probing when the answer was unclear or
contradictory, misunderstanding answers, not listening prop-
erly to answers, writing answers down incorrectly (Figure 1,
example 2), and even not asking the question but filling in an
answer anyway.
Desirability.
1. Desirability bias involves participants giving the answer that
they think the interviewer wants to hear, or not giving the
answer they think the interviewer might disapprove of.
Desirability bias led to under-reporting of sex (and conse-
quently also gel and condom use) in the CRF because some
participants perceived themselves as having a lot of sex and
were embarrassed to report this to clinic staff. These women
did loosen up and discuss this in the context of the more
informal in-depth interviews (Figure 3).
Definition and delineation.
1. Much of the under- and over-reporting stemmed from the way
in which various categories were defined and delineated by
both participants and researchers. The most common misun-
derstandings related to the definition of ‘‘sex act’’ (Figure 4).
2. Sometimes participants who had had sex in the last week were
nonetheless recorded as only having had sex in the last four
weeks during the CRF interview. As a result one week’s self-
reported gel use was compared to a month’s returned
applicators (see the section ‘‘Comparing self-reported gel use
to returned used applicators’’ above).
3. In the case of participants who had not had sex in the last week
and were supposed to be questioned about the last four weeks,
CRF interviewers sometimes asked participants about ‘‘this
month’’ rather than ‘‘the last four weeks,’’ thus missing the sex
acts and gel use in the earlier weeks if the interview fell in the
middle of the month.
4. Participants sometimes used gel without having sex, and such
use was usually not reported in the CRF interview or the CD as
‘‘gel use’’ (but did come up in the IDI). For example, some
wanted to try out the applicator or demonstrate to their
partner. Sometimes participants used gel to ‘‘cleanse’’ their
vagina, and there were unsubstantiated rumours (in the FGDs
and community ethnography) of some women using the gel as
hair gel or skin cream. As a result, used applicators did not
necessarily mean the gel had been used for sex.
5. Although they were not questioned explicitly about this, it
seems likely, from some of the IDI discussions in which
participants reported having five or six ‘‘rounds’’ during the
course of a single evening, that they did not insert a new gel for
each round but did assume when they were being questioned
that all the rounds were ‘‘sex acts with gel’’. In this case,
conversely to point 7 above, lack of used applicators did not
necessarily mean that gel was not used during sex.
Deception.
1. It is possible that some participants shared gel with other
women or squeezed out gel in order to return empty
applicators to the clinic. Although there is some evidence of
limited gel sharing, with a few participants admitting to it (for
example a women running out of gel and borrowing some from
a friend), there is only very limited indirect evidence – from the
focus group discussions and ethnography – of participants
deliberately dumping gel. Also, because the applicators were
dispensed in boxes of ten and used applicators returned in the
same boxes, some women may have emptied the last few
applicators in order to return full boxes. Although a few
participants said that they knew of other women squeezing out
the gel to empty the applicators, none ever admitted doing this
themselves.
Discussion
In this paper we have shown how a mixed method and
triangulation model, described in detail in a separate paper [1],
was used to reveal inconsistencies in the data on sexual behaviour,
gel use and condom use collected using closed structured
interviews, coital diaries and in-depth interviews. The paper has
also described the attempt to resolve these inconsistencies through
dialogue with study participants and triangulation. We have also
compared self-reported gel use with the number of used gel
applicators that participants returned to the clinic and discussed
some of the problems inherent in this comparison. We conclude
that data from the clinical CRF – the main source of self-report
data on behaviour and adherence in many studies – was least
accurate with regard to measuring sexual behaviour and gel use.
This has important implications for the use of structured
questionnaires for the collection of data on sexual behaviour and
adherence in microbicide and other similar clinical trials, and
suggests that integrating in-depth interviews and triangulation into
trials could increase both the accuracy and the richness of
behavioural and adherence data, as well as contributing to an
understanding of the reasons for inaccurate reporting. The in-
depth interview is the key to the triangulation process because it
enables critical discussion with the participant and, after it has
been transcribed and coded, it can be independently assessed and
subjected to deeper interpretation.
Table 2. Total number of reported gels used by method
compared to the number of returned used applicators.
Method Number of gels used
CRF 5897
CD 6908
IDI 7051
Triangulated 7165
Used applicator count 7001
doi:10.1371/journal.pone.0011632.t002
3
4
5
6.
7.
8
9.
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Having said that, we need to consider the limitations. We have
assumed that the triangulated result is the most accurate one,
based on consistency of the data from different sources,
verification by the participant, consistency within the IDI text
when it is analysed in detail, numbers of returned gel applicators,
and the absence of evidence to the contrary. This assumption is
plausible, and our conclusions are supported by the figures for
used applicator returns. But it is not possible to be completely
certain.
Because the triangulation/resolution process is an intrinsic part
of the IDI, and is conducted by the same interviewer, it could be
argued that the triangulated result is dependent on the skills of that
interviewer. This argument is correct, and the extent to which
inconsistencies are revealed and solved is clearly related to the skill
of the interviewer. And many of the problems that have emerged
from the CRF interview (and the mistakes made in the IDI) are
clearly related to the lack of interviewer skills. This serves to
emphasise the importance of recruiting those with the appropriate
interpersonal skills and investing in adequate training to go beyond
the simple reading of questions from a questionnaire and
superficial probing.
It could also be argued that there may be a bias towards
‘‘accepting’’ the accuracy of the (initial) IDI result, since
respondents may find it easier to say they have given misleading
information to a clinic interviewer earlier in the process than to
admit, face-to-face, that they have just misled the IDI interviewer.
However, the triangulation process reveals that 30% of the IDIs
themselves contain inaccuracies, and in these cases it has been
concluded that the CD or the CRF was more accurate, quite often
as a result of the participant herself insisting on this (see Figure 1,
example 1 and Figure 4, example 2 for participants claiming that
the CD was correct).
The process not only generated richer and plausibly more
accurate data, but also revealed weaknesses and errors across the
whole data-collection process: the mistakes of the interviewers, the
shortcomings of the closed and structured interview process, the
errors in the data, the difficulties inherent in the categories and
concepts used. Some of these could have been avoided by better
Figure 3. Desirability bias.
doi:10.1371/journal.pone.0011632.g003
Figure 4. Category misunderstandings.
doi:10.1371/journal.pone.0011632.g004
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training, more monitoring, and better quality control; others were
new and unexpected. So the process has been a double-edged
sword: more detail and more accurate data at the price of
revealing our mistakes and weaknesses. But this has also made it a
good learning experience for future studies.
And the increased ‘‘accuracy’’ still remains contentious to some
extent – the product of comparing results from different but
imperfect methods and interpretation, rather than the ‘‘gold
standard’’ craved by clinical trialists. However – and this is
another positive aspect of the learning process – we also realise
that a validated biomarker for sex or gel use would not solve all the
issues and problems identified here: we would still need to ensure
that mistakes were not made in defining and recording time
periods, that researchers and participants were using terms and
concepts in the same way, that relevant behaviours for which there
is no biomarker were accurately reported, etc. A validated
biomarker would improve the overall accuracy and the compre-
hensiveness of the process (as would better coital diaries, better
interviews, and better quality control), rather than being an
alternative. Triangulation should therefore be seen broadly, as
contributing to a more accurate and a more comprehensive
picture, rather than being narrowly focused on validating the
accuracy of a single measure.
We have revealed substantial inconsistency between the data
from different methods, but the extent of these inconsistencies is
also partly a result of the narrow definition of inconsistency: a
looser (and perhaps more realistic) definition results in fewer
inconsistencies (just as a looser definition of adherence results in
higher adherence). This implies that some critical discussion is
needed about how much inaccuracy is acceptable and what
constitutes sufficient adherence.
On the one hand, the results presented above could be
interpreted as revealing a worrying level of inconsistency in what
is generally supposed to be accurate data. Yet, given the
complexity of the behaviours being measured, the fallibility of
human memory, and the extent of things that can go wrong in
measuring such behaviour through self-report, it is perhaps
surprising how well the reported number of sex acts in the CRF
matched the triangulated figure, and how closely the reporting of
gel use in both the CRF and the triangulated data matched the
number of returned used applicators.
The data suggest that much of the inaccurate reporting is
unintentional and relatively easy to remedy through simply
discussing inconsistencies with participants. In the early stages of
designing the methodology there was some resistance to
‘‘confronting’’ participants with discrepancies in their reporting.
However, it is clear that if this is done sensitively then participants
do not find it threatening, and indeed welcome the opportunity to
correct unintentional errors that they themselves are not happy
about. Importantly, the data show that we should not assume that
study participants are generally prone to intentional deception.
It is also clear that, in spite of the generally high levels of staff
competence, training, quality control, etc. that characterised the
MDP301 trial, errors still occurred, and integrated social science
studies such as the one described in this paper and the companion
paper make it possible to identify these and suggest further
measures to avoid them (for example, in this case through trying to
improve participants’ recall by developing better memory aids or
simplifying questioning (asking only about the last act rather than
the last week), or reducing desirability bias by designing better
participant information procedures. There are examples of other
innovative approaches to some of these issues in the literature, for
example the use of interactive computer-based participant
education for informed consent [5], and the use of educational
video to improve HAART adherence [6].
The data also suggest that interviews with male partners do not
add much to the triangulation process in this type of study. Male
partners were difficult to recruit and follow up: they tended to be
mobile, employed, and generally reluctant to participate. It was
also difficult to probe about inconsistencies in the participant’s
reporting of sex because these may have been related to multiple
partners, and we were aware of the ethical and social and
implications raising such issues too critically during interviews with
male partners. Triangulating interviews with male partners may be
more meaningful where men and women are recruited together as
a couple; in a safety and acceptability study of Carraguard vaginal
gel in Thai couples, for example, it was found that sex and gel use
were well correlated in partners’ reports [7].
Finally, it might seem counter-intuitive that participants tended
to under-report gel and condom use in the CRF. Given that they
were repeatedly told by clinic staff that they should use gel and a
condom whenever they had sex, it might be expected that they
would be more inclined to over-report when asked about this in
the clinic. This was probably due to the fact that gel and condom
data were collected per sex act and, because some women under-
reported the number of sex acts due to embarrassment about
reporting what they considered to be too much sex to clinic staff,
they also had to under-report gel and condom use.
Conclusions
This paper has described some of the results relating to the
accuracy of sexual behaviour and adherence data obtained by
integrating qualitative and anthropological methods into a large
multi-site clinical trial and triangulating the results. The evidence
from this process suggests that there are significant inaccuracies in
the behavioural and adherence data collected using structured
CRF interviews in a clinic setting – the main source of such data in
many Phase III HIV prevention trials. However, the data also
show that these inaccuracies are largely unintentional, and that it
is possible to identify them relatively easily through triangulation
and correct most of them through the integration of dialogue with
participants.
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